Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App
×
The Standard Group PLC The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print operations, television, radio broadcasting, digital and online services. The Standard Group is recognized as a leading multi-media house in Kenya with a key influence in matters of national and international interest.
  • Standard Group Plc HQ Office,
  • The Standard Group Center,Mombasa Road.
  • P.O Box 30080-00100,Nairobi, Kenya.
  • Telephone number: 0203222111, 0719012111
  • Email: corporate@standardmedia.co.ke

Access to the right inhaler can change a life

 Globally, asthma affects more than 260 million people and causes over 450,000 deaths every year, most of them preventable. [Courtesy]

There is a teenager I still think about whenever we talk about asthma awareness. The young patient had been taken to hospital several times in one year for breathlessness, wheezing and cough, especially at night or after exercise. Each time, the family did what they believed was right: they reached for the familiar blue inhaler. It helped for a while, so naturally they thought asthma was under control. But it was not. What the family had never fully understood was that asthma is not only about sudden tightening of the airways. Asthma is also about inflammation. Relief was being treated. The disease itself was not.

That is why this year’s World Asthma Day theme speaks so strongly to me: “Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need.” It is a powerful reminder that asthma care has changed, but access has not changed nearly enough. Globally, asthma affects more than 260 million people and causes over 450,000 deaths every year, most of them preventable. GINA continues to emphasize that people with asthma need inhaled corticosteroid-containing treatment, ideally through a 2-in-1 inhaler that gives both relief and anti-inflammatory treatment.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902